Bread Financial Holdings, Inc.
Bread Financial Holdings, Inc. (BFHIV) Stock Competitors & Peer Comparison
See (BFHIV) competitors and their performances in Stock Market.
Peer Comparison Table: Asset Management Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BFHIV | $24.70 | +0.20% | 1.8T | N/A | N/A | N/A |
| IVSXF | $41.00 | -0.18% | 125.6B | 6.06 | $6.77 | +1.31% |
| IVSBF | $40.94 | -0.63% | 125.4B | 6.05 | $6.77 | +1.32% |
| BAMGF | $16.23 | +0.00% | 60.6B | 6.63 | $2.45 | +3.64% |
| VNGDF | $135.31 | -0.16% | 52.8B | N/A | N/A | +0.92% |
| TGOPF | $35.65 | -2.94% | 36.3B | 4.06 | $8.77 | +2.96% |
| BROXF | $15.50 | +0.00% | 34.7B | N/A | N/A | +5.77% |
| EQBBF | $28.00 | +0.00% | 32.8B | 38.36 | $0.73 | +1.61% |
| BKAMF | $14.33 | +0.00% | 32.2B | N/A | N/A | +7.74% |
| PGPHF | $1,203.09 | +0.00% | 31B | 19.42 | $61.94 | +4.25% |
Stock Comparison
BFHIV vs IVSXF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, IVSXF has a market cap of 125.6B. Regarding current trading prices, BFHIV is priced at $24.70, while IVSXF trades at $41.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas IVSXF's P/E ratio is 6.06. In terms of profitability, BFHIV's ROE is N/A, compared to IVSXF's ROE of +0.21%. Regarding short-term risk, BFHIV and IVSXF have similar daily volatility (0.00).Check IVSXF's competition here
BFHIV vs IVSBF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, IVSBF has a market cap of 125.4B. Regarding current trading prices, BFHIV is priced at $24.70, while IVSBF trades at $40.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas IVSBF's P/E ratio is 6.05. In terms of profitability, BFHIV's ROE is N/A, compared to IVSBF's ROE of +0.21%. Regarding short-term risk, BFHIV is less volatile compared to IVSBF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check IVSBF's competition here
BFHIV vs BAMGF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, BAMGF has a market cap of 60.6B. Regarding current trading prices, BFHIV is priced at $24.70, while BAMGF trades at $16.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas BAMGF's P/E ratio is 6.63. In terms of profitability, BFHIV's ROE is N/A, compared to BAMGF's ROE of +0.05%. Regarding short-term risk, BFHIV is less volatile compared to BAMGF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check BAMGF's competition here
BFHIV vs VNGDF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, VNGDF has a market cap of 52.8B. Regarding current trading prices, BFHIV is priced at $24.70, while VNGDF trades at $135.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas VNGDF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to VNGDF's ROE of +0.00%. Regarding short-term risk, BFHIV and VNGDF have similar daily volatility (0.00).Check VNGDF's competition here
BFHIV vs TGOPF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, TGOPF has a market cap of 36.3B. Regarding current trading prices, BFHIV is priced at $24.70, while TGOPF trades at $35.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas TGOPF's P/E ratio is 4.06. In terms of profitability, BFHIV's ROE is N/A, compared to TGOPF's ROE of +0.24%. Regarding short-term risk, BFHIV is less volatile compared to TGOPF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check TGOPF's competition here
BFHIV vs BROXF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, BROXF has a market cap of 34.7B. Regarding current trading prices, BFHIV is priced at $24.70, while BROXF trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas BROXF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to BROXF's ROE of +0.05%. Regarding short-term risk, BFHIV and BROXF have similar daily volatility (0.00).Check BROXF's competition here
BFHIV vs EQBBF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, EQBBF has a market cap of 32.8B. Regarding current trading prices, BFHIV is priced at $24.70, while EQBBF trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas EQBBF's P/E ratio is 38.36. In terms of profitability, BFHIV's ROE is N/A, compared to EQBBF's ROE of +0.10%. Regarding short-term risk, BFHIV is less volatile compared to EQBBF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check EQBBF's competition here
BFHIV vs BKAMF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, BKAMF has a market cap of 32.2B. Regarding current trading prices, BFHIV is priced at $24.70, while BKAMF trades at $14.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas BKAMF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to BKAMF's ROE of +0.03%. Regarding short-term risk, BFHIV and BKAMF have similar daily volatility (0.00).Check BKAMF's competition here
BFHIV vs PGPHF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, PGPHF has a market cap of 31B. Regarding current trading prices, BFHIV is priced at $24.70, while PGPHF trades at $1,203.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas PGPHF's P/E ratio is 19.42. In terms of profitability, BFHIV's ROE is N/A, compared to PGPHF's ROE of +0.65%. Regarding short-term risk, BFHIV is less volatile compared to PGPHF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check PGPHF's competition here
BFHIV vs BAMKF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, BAMKF has a market cap of 28.1B. Regarding current trading prices, BFHIV is priced at $24.70, while BAMKF trades at $12.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas BAMKF's P/E ratio is 5.11. In terms of profitability, BFHIV's ROE is N/A, compared to BAMKF's ROE of +0.05%. Regarding short-term risk, BFHIV and BAMKF have similar daily volatility (0.00).Check BAMKF's competition here
BFHIV vs BXDIF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, BXDIF has a market cap of 23.1B. Regarding current trading prices, BFHIV is priced at $24.70, while BXDIF trades at $9.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas BXDIF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to BXDIF's ROE of +0.05%. Regarding short-term risk, BFHIV and BXDIF have similar daily volatility (0.00).Check BXDIF's competition here
BFHIV vs LGGNF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, LGGNF has a market cap of 21.4B. Regarding current trading prices, BFHIV is priced at $24.70, while LGGNF trades at $3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas LGGNF's P/E ratio is 34.73. In terms of profitability, BFHIV's ROE is N/A, compared to LGGNF's ROE of +0.23%. Regarding short-term risk, BFHIV is less volatile compared to LGGNF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check LGGNF's competition here
BFHIV vs STMZF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, STMZF has a market cap of 21.4B. Regarding current trading prices, BFHIV is priced at $24.70, while STMZF trades at $19.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas STMZF's P/E ratio is -8.74. In terms of profitability, BFHIV's ROE is N/A, compared to STMZF's ROE of N/A. Regarding short-term risk, BFHIV is less volatile compared to STMZF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check STMZF's competition here
BFHIV vs IHPCF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, IHPCF has a market cap of 18.8B. Regarding current trading prices, BFHIV is priced at $24.70, while IHPCF trades at $60.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas IHPCF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to IHPCF's ROE of N/A. Regarding short-term risk, BFHIV and IHPCF have similar daily volatility (0.00).Check IHPCF's competition here
BFHIV vs BKFPF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, BKFPF has a market cap of 18.7B. Regarding current trading prices, BFHIV is priced at $24.70, while BKFPF trades at $11.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas BKFPF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to BKFPF's ROE of +0.03%. Regarding short-term risk, BFHIV is less volatile compared to BKFPF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check BKFPF's competition here
BFHIV vs HALFF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, HALFF has a market cap of 18.3B. Regarding current trading prices, BFHIV is priced at $24.70, while HALFF trades at $202.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas HALFF's P/E ratio is 9.71. In terms of profitability, BFHIV's ROE is N/A, compared to HALFF's ROE of +0.10%. Regarding short-term risk, BFHIV is less volatile compared to HALFF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check HALFF's competition here
BFHIV vs IDTVF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, IDTVF has a market cap of 18.1B. Regarding current trading prices, BFHIV is priced at $24.70, while IDTVF trades at $41.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas IDTVF's P/E ratio is 11.54. In terms of profitability, BFHIV's ROE is N/A, compared to IDTVF's ROE of +0.22%. Regarding short-term risk, BFHIV is less volatile compared to IDTVF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check IDTVF's competition here
BFHIV vs BKFAF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, BKFAF has a market cap of 17.9B. Regarding current trading prices, BFHIV is priced at $24.70, while BKFAF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas BKFAF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to BKFAF's ROE of +0.05%. Regarding short-term risk, BFHIV is less volatile compared to BKFAF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check BKFAF's competition here
BFHIV vs TGOPY Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, TGOPY has a market cap of 17.7B. Regarding current trading prices, BFHIV is priced at $24.70, while TGOPY trades at $8.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas TGOPY's P/E ratio is 4.11. In terms of profitability, BFHIV's ROE is N/A, compared to TGOPY's ROE of +0.24%. Regarding short-term risk, BFHIV is less volatile compared to TGOPY. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check TGOPY's competition here
BFHIV vs AMDUF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, AMDUF has a market cap of 17.1B. Regarding current trading prices, BFHIV is priced at $24.70, while AMDUF trades at $83.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas AMDUF's P/E ratio is 8.88. In terms of profitability, BFHIV's ROE is N/A, compared to AMDUF's ROE of +0.13%. Regarding short-term risk, BFHIV is less volatile compared to AMDUF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check AMDUF's competition here
BFHIV vs JBAXY Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, JBAXY has a market cap of 16.1B. Regarding current trading prices, BFHIV is priced at $24.70, while JBAXY trades at $15.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas JBAXY's P/E ratio is 16.92. In terms of profitability, BFHIV's ROE is N/A, compared to JBAXY's ROE of +0.11%. Regarding short-term risk, BFHIV is less volatile compared to JBAXY. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check JBAXY's competition here
BFHIV vs JBARF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, JBARF has a market cap of 15.9B. Regarding current trading prices, BFHIV is priced at $24.70, while JBARF trades at $77.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas JBARF's P/E ratio is 14.36. In terms of profitability, BFHIV's ROE is N/A, compared to JBARF's ROE of +0.11%. Regarding short-term risk, BFHIV and JBARF have similar daily volatility (0.00).Check JBARF's competition here
BFHIV vs LBGUF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, LBGUF has a market cap of 15.4B. Regarding current trading prices, BFHIV is priced at $24.70, while LBGUF trades at $62.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas LBGUF's P/E ratio is 28.44. In terms of profitability, BFHIV's ROE is N/A, compared to LBGUF's ROE of +0.10%. Regarding short-term risk, BFHIV is less volatile compared to LBGUF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check LBGUF's competition here
BFHIV vs IVTBF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, IVTBF has a market cap of 15.1B. Regarding current trading prices, BFHIV is priced at $24.70, while IVTBF trades at $25.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas IVTBF's P/E ratio is 30.31. In terms of profitability, BFHIV's ROE is N/A, compared to IVTBF's ROE of +0.12%. Regarding short-term risk, BFHIV is less volatile compared to IVTBF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check IVTBF's competition here
BFHIV vs IDDTF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, IDDTF has a market cap of 14.8B. Regarding current trading prices, BFHIV is priced at $24.70, while IDDTF trades at $34.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas IDDTF's P/E ratio is 10.60. In terms of profitability, BFHIV's ROE is N/A, compared to IDDTF's ROE of +0.22%. Regarding short-term risk, BFHIV is less volatile compared to IDDTF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check IDDTF's competition here
BFHIV vs IGIFF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, IGIFF has a market cap of 12.8B. Regarding current trading prices, BFHIV is priced at $24.70, while IGIFF trades at $54.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas IGIFF's P/E ratio is 16.02. In terms of profitability, BFHIV's ROE is N/A, compared to IGIFF's ROE of +0.13%. Regarding short-term risk, BFHIV and IGIFF have similar daily volatility (0.00).Check IGIFF's competition here
BFHIV vs SBHGF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, SBHGF has a market cap of 12.1B. Regarding current trading prices, BFHIV is priced at $24.70, while SBHGF trades at $18.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas SBHGF's P/E ratio is 6.85. In terms of profitability, BFHIV's ROE is N/A, compared to SBHGF's ROE of +0.28%. Regarding short-term risk, BFHIV is less volatile compared to SBHGF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check SBHGF's competition here
BFHIV vs GBLBY Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, GBLBY has a market cap of 12.1B. Regarding current trading prices, BFHIV is priced at $24.70, while GBLBY trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas GBLBY's P/E ratio is -33.33. In terms of profitability, BFHIV's ROE is N/A, compared to GBLBY's ROE of -0.02%. Regarding short-term risk, BFHIV is less volatile compared to GBLBY. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check GBLBY's competition here
BFHIV vs GBLBF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, GBLBF has a market cap of 11.3B. Regarding current trading prices, BFHIV is priced at $24.70, while GBLBF trades at $94.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas GBLBF's P/E ratio is -31.64. In terms of profitability, BFHIV's ROE is N/A, compared to GBLBF's ROE of -0.02%. Regarding short-term risk, BFHIV is less volatile compared to GBLBF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check GBLBF's competition here
BFHIV vs SHNWF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, SHNWF has a market cap of 11.3B. Regarding current trading prices, BFHIV is priced at $24.70, while SHNWF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas SHNWF's P/E ratio is 16.22. In terms of profitability, BFHIV's ROE is N/A, compared to SHNWF's ROE of +0.12%. Regarding short-term risk, BFHIV is less volatile compared to SHNWF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check SHNWF's competition here
BFHIV vs PSHZF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, PSHZF has a market cap of 10.3B. Regarding current trading prices, BFHIV is priced at $24.70, while PSHZF trades at $57.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas PSHZF's P/E ratio is 4.68. In terms of profitability, BFHIV's ROE is N/A, compared to PSHZF's ROE of +0.09%. Regarding short-term risk, BFHIV is less volatile compared to PSHZF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check PSHZF's competition here
BFHIV vs GSCE Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, GSCE has a market cap of 9.4B. Regarding current trading prices, BFHIV is priced at $24.70, while GSCE trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas GSCE's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to GSCE's ROE of +0.29%. Regarding short-term risk, BFHIV is less volatile compared to GSCE. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check GSCE's competition here
BFHIV vs MGPUF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, MGPUF has a market cap of 9.4B. Regarding current trading prices, BFHIV is priced at $24.70, while MGPUF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas MGPUF's P/E ratio is 23.24. In terms of profitability, BFHIV's ROE is N/A, compared to MGPUF's ROE of +0.09%. Regarding short-term risk, BFHIV and MGPUF have similar daily volatility (0.00).Check MGPUF's competition here
BFHIV vs DAXXF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, DAXXF has a market cap of 9.4B. Regarding current trading prices, BFHIV is priced at $24.70, while DAXXF trades at $230.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas DAXXF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to DAXXF's ROE of +0.00%. Regarding short-term risk, BFHIV and DAXXF have similar daily volatility (0.00).Check DAXXF's competition here
BFHIV vs STJPF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, STJPF has a market cap of 8.9B. Regarding current trading prices, BFHIV is priced at $24.70, while STJPF trades at $17.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas STJPF's P/E ratio is 13.11. In terms of profitability, BFHIV's ROE is N/A, compared to STJPF's ROE of +0.37%. Regarding short-term risk, BFHIV is less volatile compared to STJPF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check STJPF's competition here
BFHIV vs SFNXF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, SFNXF has a market cap of 8.9B. Regarding current trading prices, BFHIV is priced at $24.70, while SFNXF trades at $250.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas SFNXF's P/E ratio is 65.33. In terms of profitability, BFHIV's ROE is N/A, compared to SFNXF's ROE of +0.01%. Regarding short-term risk, BFHIV is less volatile compared to SFNXF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check SFNXF's competition here
BFHIV vs FLIVF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, FLIVF has a market cap of 7.1B. Regarding current trading prices, BFHIV is priced at $24.70, while FLIVF trades at $12.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas FLIVF's P/E ratio is 5.92. In terms of profitability, BFHIV's ROE is N/A, compared to FLIVF's ROE of +0.11%. Regarding short-term risk, BFHIV and FLIVF have similar daily volatility (0.00).Check FLIVF's competition here
BFHIV vs IVPEF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, IVPEF has a market cap of 6.7B. Regarding current trading prices, BFHIV is priced at $24.70, while IVPEF trades at $131.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas IVPEF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to IVPEF's ROE of +0.00%. Regarding short-term risk, BFHIV is less volatile compared to IVPEF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check IVPEF's competition here
BFHIV vs ONEXF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, ONEXF has a market cap of 6.5B. Regarding current trading prices, BFHIV is priced at $24.70, while ONEXF trades at $85.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas ONEXF's P/E ratio is 9.64. In terms of profitability, BFHIV's ROE is N/A, compared to ONEXF's ROE of +0.07%. Regarding short-term risk, BFHIV and ONEXF have similar daily volatility (0.00).Check ONEXF's competition here
BFHIV vs ICGUF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, ICGUF has a market cap of 6.4B. Regarding current trading prices, BFHIV is priced at $24.70, while ICGUF trades at $22.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas ICGUF's P/E ratio is 8.08. In terms of profitability, BFHIV's ROE is N/A, compared to ICGUF's ROE of +0.23%. Regarding short-term risk, BFHIV and ICGUF have similar daily volatility (0.00).Check ICGUF's competition here
BFHIV vs AZIHF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, AZIHF has a market cap of 6.4B. Regarding current trading prices, BFHIV is priced at $24.70, while AZIHF trades at $45.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas AZIHF's P/E ratio is 10.46. In terms of profitability, BFHIV's ROE is N/A, compared to AZIHF's ROE of +0.27%. Regarding short-term risk, BFHIV is less volatile compared to AZIHF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check AZIHF's competition here
BFHIV vs HRGLF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, HRGLF has a market cap of 6.2B. Regarding current trading prices, BFHIV is priced at $24.70, while HRGLF trades at $12.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas HRGLF's P/E ratio is 16.23. In terms of profitability, BFHIV's ROE is N/A, compared to HRGLF's ROE of +0.38%. Regarding short-term risk, BFHIV is less volatile compared to HRGLF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check HRGLF's competition here
BFHIV vs REVNF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, REVNF has a market cap of 6B. Regarding current trading prices, BFHIV is priced at $24.70, while REVNF trades at $33.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas REVNF's P/E ratio is 24.10. In terms of profitability, BFHIV's ROE is N/A, compared to REVNF's ROE of +0.02%. Regarding short-term risk, BFHIV and REVNF have similar daily volatility (0.00).Check REVNF's competition here
BFHIV vs VUKEF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, VUKEF has a market cap of 6B. Regarding current trading prices, BFHIV is priced at $24.70, while VUKEF trades at $61.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas VUKEF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to VUKEF's ROE of N/A. Regarding short-term risk, BFHIV and VUKEF have similar daily volatility (0.00).Check VUKEF's competition here
BFHIV vs ALITF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, ALITF has a market cap of 5.9B. Regarding current trading prices, BFHIV is priced at $24.70, while ALITF trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas ALITF's P/E ratio is 7.12. In terms of profitability, BFHIV's ROE is N/A, compared to ALITF's ROE of +0.03%. Regarding short-term risk, BFHIV and ALITF have similar daily volatility (0.00).Check ALITF's competition here
BFHIV vs AFOVF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, AFOVF has a market cap of 5.8B. Regarding current trading prices, BFHIV is priced at $24.70, while AFOVF trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas AFOVF's P/E ratio is 27.28. In terms of profitability, BFHIV's ROE is N/A, compared to AFOVF's ROE of +0.03%. Regarding short-term risk, BFHIV and AFOVF have similar daily volatility (0.00).Check AFOVF's competition here
BFHIV vs HRGLY Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, HRGLY has a market cap of 5.7B. Regarding current trading prices, BFHIV is priced at $24.70, while HRGLY trades at $23.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas HRGLY's P/E ratio is 17.32. In terms of profitability, BFHIV's ROE is N/A, compared to HRGLY's ROE of +0.50%. Regarding short-term risk, BFHIV is less volatile compared to HRGLY. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check HRGLY's competition here
BFHIV vs RMGOF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, RMGOF has a market cap of 5.6B. Regarding current trading prices, BFHIV is priced at $24.70, while RMGOF trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas RMGOF's P/E ratio is 31.14. In terms of profitability, BFHIV's ROE is N/A, compared to RMGOF's ROE of +0.04%. Regarding short-term risk, BFHIV and RMGOF have similar daily volatility (0.00).Check RMGOF's competition here
BFHIV vs HSXUF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, HSXUF has a market cap of 5.5B. Regarding current trading prices, BFHIV is priced at $24.70, while HSXUF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas HSXUF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to HSXUF's ROE of +0.00%. Regarding short-term risk, BFHIV and HSXUF have similar daily volatility (0.00).Check HSXUF's competition here
BFHIV vs TTBXF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, TTBXF has a market cap of 5.5B. Regarding current trading prices, BFHIV is priced at $24.70, while TTBXF trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas TTBXF's P/E ratio is 3.01. In terms of profitability, BFHIV's ROE is N/A, compared to TTBXF's ROE of +0.07%. Regarding short-term risk, BFHIV and TTBXF have similar daily volatility (0.00).Check TTBXF's competition here
BFHIV vs ISRPF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, ISRPF has a market cap of 5.5B. Regarding current trading prices, BFHIV is priced at $24.70, while ISRPF trades at $100.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas ISRPF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to ISRPF's ROE of +0.00%. Regarding short-term risk, BFHIV is less volatile compared to ISRPF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check ISRPF's competition here
BFHIV vs IXSRF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, IXSRF has a market cap of 5.4B. Regarding current trading prices, BFHIV is priced at $24.70, while IXSRF trades at $8.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas IXSRF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to IXSRF's ROE of +0.00%. Regarding short-term risk, BFHIV is less volatile compared to IXSRF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check IXSRF's competition here
BFHIV vs SLFPY Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, SLFPY has a market cap of 5.2B. Regarding current trading prices, BFHIV is priced at $24.70, while SLFPY trades at $11.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas SLFPY's P/E ratio is 10.17. In terms of profitability, BFHIV's ROE is N/A, compared to SLFPY's ROE of +0.08%. Regarding short-term risk, BFHIV and SLFPY have similar daily volatility (0.00).Check SLFPY's competition here
BFHIV vs CCGDF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, CCGDF has a market cap of 5.1B. Regarding current trading prices, BFHIV is priced at $24.70, while CCGDF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas CCGDF's P/E ratio is 13.37. In terms of profitability, BFHIV's ROE is N/A, compared to CCGDF's ROE of +0.02%. Regarding short-term risk, BFHIV is less volatile compared to CCGDF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check CCGDF's competition here
BFHIV vs MEIEF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, MEIEF has a market cap of 5B. Regarding current trading prices, BFHIV is priced at $24.70, while MEIEF trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas MEIEF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to MEIEF's ROE of +0.00%. Regarding short-term risk, BFHIV is less volatile compared to MEIEF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check MEIEF's competition here
BFHIV vs VGDDF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, VGDDF has a market cap of 4.9B. Regarding current trading prices, BFHIV is priced at $24.70, while VGDDF trades at $135.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas VGDDF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to VGDDF's ROE of +0.00%. Regarding short-term risk, BFHIV is less volatile compared to VGDDF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check VGDDF's competition here
BFHIV vs SLFPF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, SLFPF has a market cap of 4.8B. Regarding current trading prices, BFHIV is priced at $24.70, while SLFPF trades at $2.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas SLFPF's P/E ratio is 9.28. In terms of profitability, BFHIV's ROE is N/A, compared to SLFPF's ROE of +0.08%. Regarding short-term risk, BFHIV is less volatile compared to SLFPF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check SLFPF's competition here
BFHIV vs BBAGF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, BBAGF has a market cap of 4.7B. Regarding current trading prices, BFHIV is priced at $24.70, while BBAGF trades at $61.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas BBAGF's P/E ratio is -3.56. In terms of profitability, BFHIV's ROE is N/A, compared to BBAGF's ROE of +0.09%. Regarding short-term risk, BFHIV is less volatile compared to BBAGF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check BBAGF's competition here
BFHIV vs AMSPF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, AMSPF has a market cap of 4.3B. Regarding current trading prices, BFHIV is priced at $24.70, while AMSPF trades at $139.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas AMSPF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to AMSPF's ROE of +0.00%. Regarding short-term risk, BFHIV is less volatile compared to AMSPF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check AMSPF's competition here
BFHIV vs ISMCF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, ISMCF has a market cap of 4.3B. Regarding current trading prices, BFHIV is priced at $24.70, while ISMCF trades at $737.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas ISMCF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to ISMCF's ROE of +0.00%. Regarding short-term risk, BFHIV is less volatile compared to ISMCF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check ISMCF's competition here
BFHIV vs RITPF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, RITPF has a market cap of 4B. Regarding current trading prices, BFHIV is priced at $24.70, while RITPF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas RITPF's P/E ratio is 4.35. In terms of profitability, BFHIV's ROE is N/A, compared to RITPF's ROE of +0.12%. Regarding short-term risk, BFHIV and RITPF have similar daily volatility (0.00).Check RITPF's competition here
BFHIV vs VONHF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, VONHF has a market cap of 3.9B. Regarding current trading prices, BFHIV is priced at $24.70, while VONHF trades at $69.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas VONHF's P/E ratio is 11.90. In terms of profitability, BFHIV's ROE is N/A, compared to VONHF's ROE of +0.12%. Regarding short-term risk, BFHIV is less volatile compared to VONHF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check VONHF's competition here
BFHIV vs QUILF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, QUILF has a market cap of 3.8B. Regarding current trading prices, BFHIV is priced at $24.70, while QUILF trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas QUILF's P/E ratio is -91.67. In terms of profitability, BFHIV's ROE is N/A, compared to QUILF's ROE of +0.08%. Regarding short-term risk, BFHIV is less volatile compared to QUILF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check QUILF's competition here
BFHIV vs MNKIF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, MNKIF has a market cap of 3.7B. Regarding current trading prices, BFHIV is priced at $24.70, while MNKIF trades at $18.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas MNKIF's P/E ratio is -5.72. In terms of profitability, BFHIV's ROE is N/A, compared to MNKIF's ROE of +0.23%. Regarding short-term risk, BFHIV is less volatile compared to MNKIF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check MNKIF's competition here
BFHIV vs WNDLF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, WNDLF has a market cap of 3.7B. Regarding current trading prices, BFHIV is priced at $24.70, while WNDLF trades at $87.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas WNDLF's P/E ratio is -34.71. In terms of profitability, BFHIV's ROE is N/A, compared to WNDLF's ROE of -0.05%. Regarding short-term risk, BFHIV and WNDLF have similar daily volatility (0.00).Check WNDLF's competition here
BFHIV vs BMMWF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, BMMWF has a market cap of 3.5B. Regarding current trading prices, BFHIV is priced at $24.70, while BMMWF trades at $43.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas BMMWF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to BMMWF's ROE of +0.00%. Regarding short-term risk, BFHIV and BMMWF have similar daily volatility (0.00).Check BMMWF's competition here
BFHIV vs PVVLF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, PVVLF has a market cap of 3.5B. Regarding current trading prices, BFHIV is priced at $24.70, while PVVLF trades at $47.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas PVVLF's P/E ratio is 119.90. In terms of profitability, BFHIV's ROE is N/A, compared to PVVLF's ROE of N/A. Regarding short-term risk, BFHIV and PVVLF have similar daily volatility (0.00).Check PVVLF's competition here
BFHIV vs TKCPF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, TKCPF has a market cap of 3.2B. Regarding current trading prices, BFHIV is priced at $24.70, while TKCPF trades at $61.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas TKCPF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to TKCPF's ROE of +0.00%. Regarding short-term risk, BFHIV is less volatile compared to TKCPF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check TKCPF's competition here
BFHIV vs EUZOF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, EUZOF has a market cap of 3.1B. Regarding current trading prices, BFHIV is priced at $24.70, while EUZOF trades at $48.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas EUZOF's P/E ratio is -6.95. In terms of profitability, BFHIV's ROE is N/A, compared to EUZOF's ROE of -0.06%. Regarding short-term risk, BFHIV is less volatile compared to EUZOF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check EUZOF's competition here
BFHIV vs TKKHF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, TKKHF has a market cap of 3B. Regarding current trading prices, BFHIV is priced at $24.70, while TKKHF trades at $17.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas TKKHF's P/E ratio is 14.55. In terms of profitability, BFHIV's ROE is N/A, compared to TKKHF's ROE of +0.04%. Regarding short-term risk, BFHIV is less volatile compared to TKKHF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check TKKHF's competition here
BFHIV vs JTCPF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, JTCPF has a market cap of 2.9B. Regarding current trading prices, BFHIV is priced at $24.70, while JTCPF trades at $17.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas JTCPF's P/E ratio is -106.87. In terms of profitability, BFHIV's ROE is N/A, compared to JTCPF's ROE of +0.00%. Regarding short-term risk, BFHIV and JTCPF have similar daily volatility (0.00).Check JTCPF's competition here
BFHIV vs RTBBF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, RTBBF has a market cap of 2.9B. Regarding current trading prices, BFHIV is priced at $24.70, while RTBBF trades at $27.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas RTBBF's P/E ratio is 19.54. In terms of profitability, BFHIV's ROE is N/A, compared to RTBBF's ROE of +0.08%. Regarding short-term risk, BFHIV is less volatile compared to RTBBF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check RTBBF's competition here
BFHIV vs BZSPF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, BZSPF has a market cap of 2.8B. Regarding current trading prices, BFHIV is priced at $24.70, while BZSPF trades at $77.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas BZSPF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to BZSPF's ROE of +0.00%. Regarding short-term risk, BFHIV is less volatile compared to BZSPF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check BZSPF's competition here
BFHIV vs NINTF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, NINTF has a market cap of 2.6B. Regarding current trading prices, BFHIV is priced at $24.70, while NINTF trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas NINTF's P/E ratio is 11.96. In terms of profitability, BFHIV's ROE is N/A, compared to NINTF's ROE of +0.41%. Regarding short-term risk, BFHIV and NINTF have similar daily volatility (0.00).Check NINTF's competition here
BFHIV vs CALEF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, CALEF has a market cap of 2.3B. Regarding current trading prices, BFHIV is priced at $24.70, while CALEF trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas CALEF's P/E ratio is 0.33. In terms of profitability, BFHIV's ROE is N/A, compared to CALEF's ROE of +0.06%. Regarding short-term risk, BFHIV and CALEF have similar daily volatility (0.00).Check CALEF's competition here
BFHIV vs ENDTF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, ENDTF has a market cap of 2.3B. Regarding current trading prices, BFHIV is priced at $24.70, while ENDTF trades at $12.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas ENDTF's P/E ratio is 23.92. In terms of profitability, BFHIV's ROE is N/A, compared to ENDTF's ROE of +0.12%. Regarding short-term risk, BFHIV is less volatile compared to ENDTF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check ENDTF's competition here
BFHIV vs TXEMF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, TXEMF has a market cap of 2.3B. Regarding current trading prices, BFHIV is priced at $24.70, while TXEMF trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas TXEMF's P/E ratio is -5.23. In terms of profitability, BFHIV's ROE is N/A, compared to TXEMF's ROE of +0.08%. Regarding short-term risk, BFHIV is less volatile compared to TXEMF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check TXEMF's competition here
BFHIV vs XTRTF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, XTRTF has a market cap of 2.2B. Regarding current trading prices, BFHIV is priced at $24.70, while XTRTF trades at $129.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas XTRTF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to XTRTF's ROE of N/A. Regarding short-term risk, BFHIV is less volatile compared to XTRTF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check XTRTF's competition here
BFHIV vs CRPFY Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, CRPFY has a market cap of 2.2B. Regarding current trading prices, BFHIV is priced at $24.70, while CRPFY trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas CRPFY's P/E ratio is 4.05. In terms of profitability, BFHIV's ROE is N/A, compared to CRPFY's ROE of +0.04%. Regarding short-term risk, BFHIV and CRPFY have similar daily volatility (0.00).Check CRPFY's competition here
BFHIV vs CEVIF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, CEVIF has a market cap of 2.1B. Regarding current trading prices, BFHIV is priced at $24.70, while CEVIF trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas CEVIF's P/E ratio is -61.50. In terms of profitability, BFHIV's ROE is N/A, compared to CEVIF's ROE of -0.07%. Regarding short-term risk, BFHIV and CEVIF have similar daily volatility (0.00).Check CEVIF's competition here
BFHIV vs FFXDF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, FFXDF has a market cap of 1.9B. Regarding current trading prices, BFHIV is priced at $24.70, while FFXDF trades at $18.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas FFXDF's P/E ratio is 6.05. In terms of profitability, BFHIV's ROE is N/A, compared to FFXDF's ROE of +0.15%. Regarding short-term risk, BFHIV is less volatile compared to FFXDF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check FFXDF's competition here
BFHIV vs AJMPF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, AJMPF has a market cap of 1.9B. Regarding current trading prices, BFHIV is priced at $24.70, while AJMPF trades at $2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas AJMPF's P/E ratio is 13.32. In terms of profitability, BFHIV's ROE is N/A, compared to AJMPF's ROE of +0.15%. Regarding short-term risk, BFHIV and AJMPF have similar daily volatility (0.00).Check AJMPF's competition here
BFHIV vs WTNTF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, WTNTF has a market cap of 1.8B. Regarding current trading prices, BFHIV is priced at $24.70, while WTNTF trades at $2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas WTNTF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to WTNTF's ROE of +0.12%. Regarding short-term risk, BFHIV and WTNTF have similar daily volatility (0.00).Check WTNTF's competition here
BFHIV vs SFFFF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, SFFFF has a market cap of 1.8B. Regarding current trading prices, BFHIV is priced at $24.70, while SFFFF trades at $71.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas SFFFF's P/E ratio is 10.82. In terms of profitability, BFHIV's ROE is N/A, compared to SFFFF's ROE of +0.06%. Regarding short-term risk, BFHIV is less volatile compared to SFFFF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check SFFFF's competition here
BFHIV vs BLGFF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, BLGFF has a market cap of 1.7B. Regarding current trading prices, BFHIV is priced at $24.70, while BLGFF trades at $4.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas BLGFF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to BLGFF's ROE of N/A. Regarding short-term risk, BFHIV is less volatile compared to BLGFF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check BLGFF's competition here
BFHIV vs BHMDF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, BHMDF has a market cap of 1.6B. Regarding current trading prices, BFHIV is priced at $24.70, while BHMDF trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas BHMDF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to BHMDF's ROE of +0.09%. Regarding short-term risk, BFHIV is less volatile compared to BHMDF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check BHMDF's competition here
BFHIV vs HNDEF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, HNDEF has a market cap of 1.6B. Regarding current trading prices, BFHIV is priced at $24.70, while HNDEF trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas HNDEF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to HNDEF's ROE of N/A. Regarding short-term risk, BFHIV is less volatile compared to HNDEF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check HNDEF's competition here
BFHIV vs FECHF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, FECHF has a market cap of 1.6B. Regarding current trading prices, BFHIV is priced at $24.70, while FECHF trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas FECHF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to FECHF's ROE of +0.00%. Regarding short-term risk, BFHIV is less volatile compared to FECHF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check FECHF's competition here
BFHIV vs CYMBF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, CYMBF has a market cap of 1.5B. Regarding current trading prices, BFHIV is priced at $24.70, while CYMBF trades at $65.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas CYMBF's P/E ratio is 7.31. In terms of profitability, BFHIV's ROE is N/A, compared to CYMBF's ROE of +0.15%. Regarding short-term risk, BFHIV and CYMBF have similar daily volatility (0.00).Check CYMBF's competition here
BFHIV vs EHITF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, EHITF has a market cap of 1.4B. Regarding current trading prices, BFHIV is priced at $24.70, while EHITF trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas EHITF's P/E ratio is 10.85. In terms of profitability, BFHIV's ROE is N/A, compared to EHITF's ROE of +0.07%. Regarding short-term risk, BFHIV and EHITF have similar daily volatility (0.00).Check EHITF's competition here
BFHIV vs ISCMF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, ISCMF has a market cap of 1.4B. Regarding current trading prices, BFHIV is priced at $24.70, while ISCMF trades at $7.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas ISCMF's P/E ratio is N/A. In terms of profitability, BFHIV's ROE is N/A, compared to ISCMF's ROE of N/A. Regarding short-term risk, BFHIV and ISCMF have similar daily volatility (0.00).Check ISCMF's competition here
BFHIV vs AVGTF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, AVGTF has a market cap of 1.4B. Regarding current trading prices, BFHIV is priced at $24.70, while AVGTF trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas AVGTF's P/E ratio is 16.80. In terms of profitability, BFHIV's ROE is N/A, compared to AVGTF's ROE of +0.11%. Regarding short-term risk, BFHIV is less volatile compared to AVGTF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check AVGTF's competition here
BFHIV vs PPTTF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, PPTTF has a market cap of 1.3B. Regarding current trading prices, BFHIV is priced at $24.70, while PPTTF trades at $11.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas PPTTF's P/E ratio is -95.00. In terms of profitability, BFHIV's ROE is N/A, compared to PPTTF's ROE of -0.01%. Regarding short-term risk, BFHIV and PPTTF have similar daily volatility (0.00).Check PPTTF's competition here
BFHIV vs BWMTF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, BWMTF has a market cap of 1.3B. Regarding current trading prices, BFHIV is priced at $24.70, while BWMTF trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas BWMTF's P/E ratio is 5.37. In terms of profitability, BFHIV's ROE is N/A, compared to BWMTF's ROE of -0.02%. Regarding short-term risk, BFHIV and BWMTF have similar daily volatility (0.00).Check BWMTF's competition here
BFHIV vs JFHHF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, JFHHF has a market cap of 1.3B. Regarding current trading prices, BFHIV is priced at $24.70, while JFHHF trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas JFHHF's P/E ratio is 10.88. In terms of profitability, BFHIV's ROE is N/A, compared to JFHHF's ROE of +0.11%. Regarding short-term risk, BFHIV and JFHHF have similar daily volatility (0.00).Check JFHHF's competition here
BFHIV vs GRWXF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, GRWXF has a market cap of 1.3B. Regarding current trading prices, BFHIV is priced at $24.70, while GRWXF trades at $7.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas GRWXF's P/E ratio is 8.98. In terms of profitability, BFHIV's ROE is N/A, compared to GRWXF's ROE of +0.09%. Regarding short-term risk, BFHIV and GRWXF have similar daily volatility (0.00).Check GRWXF's competition here
BFHIV vs RTOBF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, RTOBF has a market cap of 1.3B. Regarding current trading prices, BFHIV is priced at $24.70, while RTOBF trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas RTOBF's P/E ratio is -16.96. In terms of profitability, BFHIV's ROE is N/A, compared to RTOBF's ROE of +0.16%. Regarding short-term risk, BFHIV is less volatile compared to RTOBF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check RTOBF's competition here
BFHIV vs GCAAF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, GCAAF has a market cap of 1.2B. Regarding current trading prices, BFHIV is priced at $24.70, while GCAAF trades at $49.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas GCAAF's P/E ratio is 9.06. In terms of profitability, BFHIV's ROE is N/A, compared to GCAAF's ROE of +0.14%. Regarding short-term risk, BFHIV is less volatile compared to GCAAF. This indicates potentially lower risk in terms of short-term price fluctuations for BFHIV.Check GCAAF's competition here
BFHIV vs MGLLF Comparison April 2026
BFHIV plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFHIV stands at 1.8T. In comparison, MGLLF has a market cap of 1.2B. Regarding current trading prices, BFHIV is priced at $24.70, while MGLLF trades at $6.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFHIV currently has a P/E ratio of N/A, whereas MGLLF's P/E ratio is 8.79. In terms of profitability, BFHIV's ROE is N/A, compared to MGLLF's ROE of +0.14%. Regarding short-term risk, BFHIV and MGLLF have similar daily volatility (0.00).Check MGLLF's competition here